Improvement in patient-reported sleep in type 2 diabetes and prediabetes participants receiving a continuous care intervention with nutritional ketosis

被引:20
作者
Siegmann, Morgan J. [1 ,2 ,3 ]
Athinarayanan, Shaminie J. [4 ]
Hallberg, Sarah J. [4 ,5 ]
McKenzie, Amy L. [4 ]
Bhanpuri, Nasir H. [4 ]
Campbell, Wayne W. [6 ]
McCarter, James P. [4 ,7 ]
Phinney, Stephen D. [4 ]
Volek, Jeff S. [4 ,8 ]
Van Dort, Christa J. [1 ,2 ,3 ]
机构
[1] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA
[2] Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA
[3] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA
[4] Virta Hlth, 535 Mission St, San Francisco, CA USA
[5] Indiana Univ Hlth Arnett, Lafayette, IN USA
[6] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA
[7] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA
[8] Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA
关键词
Type; 2; diabetes; Prediabetes; Ketogenic diet; PSQI; Nutritional ketosis; EXCESSIVE DAYTIME SLEEPINESS; WEIGHT-LOSS; GLYCEMIC CONTROL; INSULIN-RESISTANCE; KETOGENIC DIET; OBESE-PATIENTS; QUALITY; APNEA; CHOLECYSTOKININ; DURATION;
D O I
10.1016/j.sleep.2018.12.014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Sleep disruption is frequently associated with type 2 diabetes (T2D) and hyperglycemia. We recently reported the effectiveness of a continuous care intervention (CCI) emphasizing nutritional ketosis for improving HbA1c, body weight and cardiovascular risk factors in T2D patients. The present study assessed the effect of this CCI approach on sleep quality using a subjective patient-reported sleep questionnaire. Methods: A non-randomized, controlled longitudinal study; 262 T2D and 116 prediabetes patients enrolled in the CCI and 87 separately recruited T2D patients continued usual care (UC) treatment. Patients completed the Pittsburgh Sleep Quality Index (PSQI) questionnaire. A PSQI score of >5 (scale 0 to 21) was used to identify poor sleepers. Results: Global sleep quality improved in the CCI T2D (p < 0.001) and prediabetes (p < 0.001) patients after one year of intervention. Subjective sleep quality (component 1), sleep disturbance (component 5) and daytime dysfunction (component 7), also showed improvements in the CCI T2D (p < 0.01 for sleep quality and sleep disturbance; and p < 0.001 for daytime dysfunction) and prediabetes patients (p < 0.001 for all three components); compared to the UC T2D group after one year. The proportion of patients with poor sleep quality was significantly reduced after one year of CCI (T2D; from 68.3% at baseline to 56.5% at one year, p = 0.001 and prediabetes; from 77.9% at baseline to 48.7% at one year, p < 0.001). Conclusion: This study demonstrates improved sleep quality as assessed by PSQI in patients with T2D and prediabetes undergoing CCI including nutritional ketosis but not in T2D patients receiving UC. The dietary intervention benefited both sleep quality and the severity of T2D symptoms suggesting that nutritional ketosis improves overall health via multiple mechanisms. (c) 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:92 / 99
页数:8
相关论文
共 50 条
  • [41] Association of hypoglycaemia severity with clinical, patient-reported and economic outcomes in US patients with type 2 diabetes using basal insulin
    Meneghini, Luigi F.
    Lee, Lulu K.
    Gupta, Shaloo
    Preblick, Ron
    DIABETES OBESITY & METABOLISM, 2018, 20 (05) : 1156 - 1165
  • [42] Patient-reported Outcomes in Patients with Type 2 Diabetes Treated with Dulaglutide Added to Titrated Insulin Glargine (AWARD-9)
    Yu, Maria
    Van Brunt, Kate
    Milicevic, Zvonko
    Varnado, Oralee
    Boye, Kristina S.
    CLINICAL THERAPEUTICS, 2017, 39 (11) : 2284 - 2295
  • [43] Patient-reported outcomes in trials of incretin-based therapies in patients with type 2 diabetes mellitus
    Davies, M.
    Speight, J.
    DIABETES OBESITY & METABOLISM, 2012, 14 (10) : 882 - 892
  • [44] Development and validation of a Type 1 and Type 2 diabetes-specific patient-reported experience measure e-questionnaire: Diabetes reported experience measures (DREMS)
    Hehn, Coline
    Ounajim, Amine
    Fagherazzi, Guy
    Gasch-Illescas, Antonia
    Montagu, Guillaume
    Rumeau-Pichon, Catherine
    Elissalde, Jean-Arnaud
    Braithwaite, Ben
    Servy, Herve
    Thivolet, Charles
    Thebaut, Jean-Francois
    Naiditch, Nicolas
    DIABETES EPIDEMIOLOGY AND MANAGEMENT, 2024, 13
  • [45] Patient-reported outcome measures for assessing health-related quality of life in people with type 2 diabetes: A systematic review
    Langendoen-Gort, Marlous
    Groeneveld, Lenka
    Prinsen, Cecilia A. C.
    Beulens, Joline W.
    Elders, Petra J. M.
    Halperin, Ilana
    Mukerji, Geetha
    Terwee, Caroline B.
    Rutters, Femke
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2022, 23 (05) : 931 - 977
  • [46] A Systematic Analysis of Reviews Exploring the Scope, Validity, and Reporting of Patient-Reported Outcomes Measures of Medication Adherence in Type 2 Diabetes
    Wells, Joshua
    Crilly, Philip
    Kayyali, Reem
    PATIENT PREFERENCE AND ADHERENCE, 2022, 16 : 1941 - 1954
  • [47] Quality of life and other patient-reported outcomes in adult Lebanese patients with type 2 diabetes during COVID-19 pandemic
    Naous, E.
    Boulos, M.
    Sleilaty, G.
    Achkar, A. A.
    Gannage-Yared, M-H
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (04) : 763 - 772
  • [48] Patient-reported outcomes among patients with type 2 diabetes mellitus treated with dapagliflozin in a triple-therapy regimen for 52 weeks
    Grandy, S.
    Sternhufvud, C.
    Ryden, A.
    Sugg, J.
    Rohwedder, K.
    DIABETES OBESITY & METABOLISM, 2016, 18 (03) : 306 - 309
  • [49] Oral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies
    Rudofsky, Gottfried
    Amadid, Hanan
    Braae, Uffe Christian
    Catrina, Sergiu-Bogdan
    Kick, Anastas
    Mandavya, Kabirdev
    Roslind, Klaus
    Saravanan, Ponnusamy
    van Houtum, William
    Jain, Akshay B.
    DIABETES THERAPY, 2025, 16 (01) : 73 - 87
  • [50] Effects of insulin initiation on patient-reported outcomes in patients with type 2 diabetes: Results from the DURABLE trial
    Lee, Lauren J.
    Fahrbach, Jessie L.
    Nelson, Lauren M.
    McLeod, Lori D.
    Martin, Sherry A.
    Sun, Peter
    Weinstock, Ruth S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 89 (02) : 157 - 166